Skip to content

A verification test of psychological and physiological effects of aroma or intake of coffee.

A verification test of psychological and physiological effects of aroma or intake of coffee. - A verification test of psychological and physiological effects of aroma or intake of coffee.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039318
Enrollment
20
Registered
2020-08-31
Start date
2019-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Resting more than 10min- measurements and questionnaires- suctioning coffee aroma- measurements and questionnaires- intake coffee- resting- measurements and questionnaires- resting- measurements and

Sponsors

NIHON UNIVERSITY
Lead Sponsor
University of Tsukuba, School of Integrative
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and female who are students of NIHON UNIVERSITY aged more than 20 years when informed consent. 2. Subjects who are able to intake coffee. 3. Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1.Subjects who don't good at coffee aroma 2. Subjects who have smoking habit. 3. Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) 4. Subjects who are receiving medication due to treatment of disease. 5. In a past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. (Except for cold but include for pollen allergy.) 6. Subjects who have stuffy nose such as allergic rhinitis, or subjects who are not able to determine aroma. 7. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 8. Pregnant or expected pregnant, or lactating women. 9. Subjects who have symptom of dermatologic disease such as atopic dermatitis. 10. Subjects who feel pain in their knee, or subjects who feel pain or discomfort when bent their knee. 11. Subjects who have undergone surgery on investigation objective portion within the past 6 months. 12. Subjects who are participating the other clinical tests. Subjects who participated within a month prior to the current study and/or who plan to participate the other clinical tests. 13. Other who is determined ineligible by investigator.

Design outcomes

Primary

MeasureTime frame
*Evaluation of autonomic nervous system, by iris measurement, skin temperature measurement and heart rate change * Evaluation of parasympathetic nervous system, by measurement for function of field of view and stabilometry *Flicker test

Secondary

MeasureTime frame
*POMS2 short version *VAS questionnaire

Countries

Japan

Contacts

Public ContactYukihiro Yada

University of Tsukuba, School of Integrative Global Majors

yada.yukihiro.gb@u.tsukuba.ac.jp029-853-7344

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026